Brown Brothers Harriman & Co’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.11M | Buy |
5,302
+2,489
| +88% | +$709K | 0.01% | 351 |
|
|
2026
Q1 | $488K | Buy |
2,813
+668
| +31% | +$137K | ﹤0.01% | 615 |
|
|
2025
Q4 | $549K | Buy |
2,145
+427
| +25% | +$112K | ﹤0.01% | 507 |
|
|
2025
Q3 | $447K | Buy |
1,718
+1,641
| +2,131% | +$432K | ﹤0.01% | 508 |
|
|
2025
Q2 | $18.8K | Buy |
77
+58
| +305% | +$14.5K | ﹤0.01% | 1102 |
|
|
2025
Q1 | $5.03K | Hold |
19
| – | – | ﹤0.01% | 1162 |
|
|
2024
Q4 | $4.82K | Sell |
19
-148
| -89% | -$39.7K | ﹤0.01% | 1238 |
|
|
2024
Q3 | $52.9K | Sell |
167
-615
| -79% | -$219K | ﹤0.01% | 803 |
|
|
2024
Q2 | $292K | Hold |
782
| – | – | ﹤0.01% | 481 |
|
|
2024
Q1 | $271K | Buy |
782
+50
| +7% | +$18.9K | ﹤0.01% | 474 |
|
|
2023
Q4 | $335K | Hold |
732
| – | – | ﹤0.01% | 419 |
|
|
2023
Q3 | $356K | Hold |
732
| – | – | ﹤0.01% | 388 |
|
|
2023
Q2 | $327K | Sell |
732
-6
| -0.8% | -$3.02K | ﹤0.01% | 389 |
|
|
2023
Q1 | $358K | Buy |
738
+19
| +3% | +$9.39K | ﹤0.01% | 387 |
|
|
2022
Q4 | $368K | Sell |
719
-10
| -1% | -$5.26K | ﹤0.01% | 359 |
|
|
2022
Q3 | $354K | Buy |
729
+60
| +9% | +$29.2K | ﹤0.01% | 356 |
|
|
2022
Q2 | $313K | Buy |
669
+23
| +4% | +$10.2K | ﹤0.01% | 386 |
|
|
2022
Q1 | $281K | Buy |
646
+610
| +1,694% | +$255K | ﹤0.01% | 441 |
|
|
2021
Q4 | $17K | Sell |
36
-125
| -78% | -$55.3K | ﹤0.01% | 853 |
|
|
2021
Q3 | $63K | Buy |
161
+123
| +324% | +$52.2K | ﹤0.01% | 639 |
|
|
2021
Q2 | $17K | Buy |
38
+4
| +12% | +$1.75K | ﹤0.01% | 830 |
|
|
2021
Q1 | $14K | Sell |
34
-170
| -83% | -$67.9K | ﹤0.01% | 823 |
|
|
2020
Q4 | $84K | Sell |
204
-12
| -6% | -$4.99K | ﹤0.01% | 584 |
|
|
2020
Q3 | $89K | Hold |
216
| – | – | ﹤0.01% | 508 |
|
|
2020
Q2 | $84K | Buy |
216
+10
| +5% | +$3.74K | ﹤0.01% | 511 |
|
|
2020
Q1 | $65K | Buy |
206
+187
| +984% | +$63.1K | ﹤0.01% | 502 |
|
|
2019
Q4 | $7K | Hold |
19
| – | – | ﹤0.01% | 939 |
|
|
2019
Q3 | $5K | Buy |
19
+16
| +533% | +$4.49K | ﹤0.01% | 988 |
|
|
2019
Q2 | $1K | Sell |
3
-5
| -63% | -$1.27K | ﹤0.01% | 1019 |
|
|
2019
Q1 | $2K | Sell |
8
-27
| -77% | -$7.78K | ﹤0.01% | 952 |
|
|
2018
Q4 | $10K | Buy |
+35
| New | +$11.1K | ﹤0.01% | 692 |
|
|
2018
Q1 | – | Sell |
-113
| Closed | -$28K | – | 947 |
|
|
2017
Q4 | $28K | Sell |
113
-227
| -67% | -$56.1K | ﹤0.01% | 589 |
|
|
2017
Q3 | $83K | Sell |
340
-375
| -52% | -$91.9K | ﹤0.01% | 426 |
|
|
2017
Q2 | $172K | Hold |
715
| – | – | ﹤0.01% | 338 |
|
|
2017
Q1 | $147K | Buy |
715
+70
| +11% | +$14.5K | ﹤0.01% | 370 |
|
|
2016
Q4 | $132K | Sell |
645
-110
| -15% | -$21K | ﹤0.01% | 355 |
|
|
2016
Q3 | $134K | Buy |
+755
| New | +$131K | ﹤0.01% | 347 |
|
|
2014
Q4 | – | Sell |
-8
| Closed | -$1K | – | 886 |
|
|
2014
Q3 | $1K | Sell |
8
-432
| -98% | -$54.9K | ﹤0.01% | 737 |
|
|
2014
Q2 | $56K | Buy |
440
+406
| +1,194% | +$48.1K | ﹤0.01% | 494 |
|
|
2014
Q1 | $4K | Buy |
+34
| New | +$3.54K | ﹤0.01% | 723 |
|
Other funds holding HUM
SC
Brown Brothers Harriman & Co's HUM Position: Q2 2026 in Review
Brown Brothers Harriman & Co increased its Humana (HUM) stake by 88% in Q2 2026, buying an estimated $709K and bringing the position to 5,302 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #351.
Brown Brothers Harriman & Co first reported a position in HUM in Q1 2014 and has held it in 40 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Brown Brothers Harriman & Co held 5,302 shares of Humana worth $2.11M as of Q2 2026.
- Brown Brothers Harriman & Co bought 2,489 Humana shares in Q2 2026, an estimated $709K.
- Humana made up 0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #351 holding.
- Brown Brothers Harriman & Co first reported a position in Humana in Q1 2014 and has held it in 40 quarters since.
- 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.